Pages that link to "Q73616962"
Jump to navigation
Jump to search
The following pages link to Effect of 8 week intake of probiotic milk products on risk factors for cardiovascular diseases (Q73616962):
Displaying 54 items.
- Fermented milk for hypertension (Q24200294) (← links)
- Effects of Probiotics and Synbiotics on Obesity, Insulin Resistance Syndrome, Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease: A Review of Human Clinical Trials (Q26745869) (← links)
- Diet, Microbiota, Obesity, and NAFLD: A Dangerous Quartet (Q26752614) (← links)
- Meta-Analysis: Effects of Probiotic Supplementation on Lipid Profiles in Normal to Mildly Hypercholesterolemic Individuals (Q26782512) (← links)
- Modulation of the gut microbiota by nutrients with prebiotic and probiotic properties (Q26823918) (← links)
- Influence of dairy product and milk fat consumption on cardiovascular disease risk: a review of the evidence (Q28266641) (← links)
- Effects of Bifidobacterium animalis subsp. lactis BB-12® on the lipid/lipoprotein profile and short chain fatty acids in healthy young adults: a randomized controlled trial (Q32175589) (← links)
- Dose-response study of probiotic bacteria Bifidobacterium animalis subsp lactis BB-12 and Lactobacillus paracasei subsp paracasei CRL-341 in healthy young adults. (Q33435312) (← links)
- Effect of symbiotic supplementation on glycemic control, lipid profiles and microalbuminuria in patients with non-obese type 2 diabetes: a randomized, double-blind, clinical trial (Q33759621) (← links)
- The Microbiome and Blood Pressure: Can Microbes Regulate Our Blood Pressure? (Q33810037) (← links)
- Long-term consumption of fermented dairy products over 6 months increases HDL cholesterol (Q34147486) (← links)
- Prophylactic and therapeutic uses of probiotics: a review (Q34197047) (← links)
- Effect of probiotic fermented milk on blood pressure: a meta-analysis of randomised controlled trials (Q34792447) (← links)
- Intake of probiotic food and risk of preeclampsia in primiparous women: the Norwegian Mother and Child Cohort Study (Q35465853) (← links)
- ACE2 and Microbiota: Emerging Targets for Cardiopulmonary Disease Therapy (Q35760437) (← links)
- Scientific evidence for health effects attributed to the consumption of probiotics and prebiotics: an update for current perspectives and future challenges. (Q35800667) (← links)
- Microbiotal-Host Interactions and Hypertension. (Q36345318) (← links)
- Antioxidative potential of folate producing probiotic Lactobacillus helveticus CD6 (Q36550377) (← links)
- Effect of Cucurbita ficifolia and Probiotic Yogurt Consumption on Blood Glucose, Lipid Profile, and Inflammatory Marker in Type 2 Diabetes (Q36606608) (← links)
- Effect of short-term probiotic Enterococcus faecium SF68 dietary supplementation in overweight and obese cats without comorbidities (Q36819280) (← links)
- The Effects of an Olive Fruit Polyphenol-Enriched Yogurt on Body Composition, Blood Redox Status, Physiological and Metabolic Parameters and Yogurt Microflora (Q37045121) (← links)
- Effects of a ferment soy product on the adipocyte area reduction and dyslipidemia control in hypercholesterolemic adult male rats (Q37067546) (← links)
- Effects of probiotic bacteria, isoflavones and simvastatin on lipid profile and atherosclerosis in cholesterol-fed rabbits: a randomized double-blind study (Q37067559) (← links)
- Effect of Probiotics on Blood Lipid Concentrations: A Meta-Analysis of Randomized Controlled Trials (Q37176141) (← links)
- Beneficial health effects of milk and fermented dairy products--review (Q37351569) (← links)
- Probiotic properties of Enterococcus strains isolated from traditional naturally fermented cream in China (Q37353482) (← links)
- The improvement of hypertension by probiotics: effects on cholesterol, diabetes, renin, and phytoestrogens (Q37403044) (← links)
- Lactobacillus casei strain C1 attenuates vascular changes in spontaneously hypertensive rats (Q37409977) (← links)
- Enterococcus durans EP1 a Promising Anti-inflammatory Probiotic Able to Stimulate sIgA and to Increase Faecalibacterium prausnitzii Abundance (Q37634649) (← links)
- Probiotics and Disease: A Comprehensive Summary-Part 3, Cardiometabolic Disease and Fatigue Syndromes (Q38754711) (← links)
- Dairy food products: good or bad for cardiometabolic disease? (Q38964086) (← links)
- Cholesterol assimilation by lactic acid bacteria and bifidobacteria isolated from the human gut (Q39640631) (← links)
- Consumption of dairy foods in relation to impaired glucose metabolism and type 2 diabetes mellitus: the Maastricht Study. (Q39975351) (← links)
- Effects of Probiotics, Prebiotics, and Synbiotics on Human Health (Q40044003) (← links)
- Lactobacillus rhamnosus BFE 5264 and Lactobacillus plantarum NR74 Promote Cholesterol Excretion Through the Up-Regulation of ABCG5/8 in Caco-2 Cells (Q40092706) (← links)
- Effect of fermented milk containing Lactobacillus acidophilus and Bifidobacterium longum on plasma lipids of women with normal or moderately elevated cholesterol (Q43262457) (← links)
- Effect of functional yogurt NY-YP901 in improving the trait of metabolic syndrome (Q43948214) (← links)
- Lactobacilli and enterococci--potential probiotics for dogs (Q44959202) (← links)
- Effect of Lactobacillus on body weight and body fat in overweight subjects: a systematic review of randomized controlled clinical trials (Q46323567) (← links)
- Antibiotic resistance and virulence factors among clinical and food enterococci isolated in Slovakia. (Q46479543) (← links)
- Dietary combination of soy with a probiotic or prebiotic food significantly reduces total and LDL cholesterol in mildly hypercholesterolaemic subjects (Q46947335) (← links)
- Kefir drink leads to a similar weight loss, compared with milk, in a dairy-rich non-energy-restricted diet in overweight or obese premenopausal women: a randomized controlled trial (Q47407908) (← links)
- Timing of probiotic milk consumption during pregnancy and effects on the incidence of preeclampsia and preterm delivery: a prospective observational cohort study in Norway (Q47557349) (← links)
- Effect of multi-strain probiotics (multi-strain microbial cell preparation) on glycemic control and other diabetes-related outcomes in people with type 2 diabetes: a randomized controlled trial (Q50224848) (← links)
- Lactobacillus acidophilus Increases the Anti-apoptotic Micro RNA-21 and Decreases the Pro-inflammatory Micro RNA-155 in the LPS-Treated Human Endothelial Cells. (Q50654029) (← links)
- Probiotic supplementation increases obesity with no detectable effects on liver fat or gut microbiota in obese Hispanic adolescents: a 16-week, randomized, placebo-controlled trial. (Q54323214) (← links)
- Modulation of the peripheral blood transcriptome by the ingestion of probiotic yoghurt and acidified milk in healthy, young men. (Q55118518) (← links)
- The antihypertensive effect of fermented milk in individuals with prehypertension or borderline hypertension (Q57402018) (← links)
- Effects of Prebiotic and Synbiotic Supplementation on Glycaemia and Lipid Profile in Type 2 Diabetes: A Meta-Analysis of Randomized Controlled Trials (Q60925810) (← links)
- Impact of bacterial probiotics on obesity, diabetes and non-alcoholic fatty liver disease related variables: a systematic review and meta-analysis of randomised controlled trials (Q64099563) (← links)
- Lactobacillus acidophilus 74-2 and Bifidobacterium animalis subsp lactis DGCC 420 modulate unspecific cellular immune response in healthy adults (Q80172504) (← links)
- Cholesterol-lowering efficacy of a microencapsulated bile salt hydrolase-active Lactobacillus reuteri NCIMB 30242 yoghurt formulation in hypercholesterolaemic adults (Q82428658) (← links)
- Cholesterol lowering and inhibition of sterol absorption by Lactobacillus reuteri NCIMB 30242: a randomized controlled trial (Q84993350) (← links)
- Potential benefits of garlic and other dietary supplements for the management of hypertension (Q89495872) (← links)